SCHEMBL7542793

SCHEMBL7542793

O=NN(c1ccccc1O)c1ccccc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.52
KDM4E B2RXH2 5/20 0.52
HPGD P15428 5/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
HMGB1 P09429 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
CA14 Q9ULX7 1/20 0.52
ALOX15 P16050 2/20 0.43
G6PD P11413 1/20 0.42
CASP7 P55210 1/20 0.42
CASP6 P55212 1/20 0.42
PTPN1 P18031 3/20 0.40
HSD17B10 Q99714 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195145 0.91 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
SCHEMBL7538439 0.85 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
SCHEMBL7193291 0.82 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
SCHEMBL7188416 0.79 NR4A1 (0.56) KDM4EHPGDSMN1; SMN2PTPN1HSD17B10
SCHEMBL7539891 0.79 PTPN1 (0.44) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
SCHEMBL7191619 0.78 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
SCHEMBL11444283 0.75 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
SCHEMBL7536404 0.72 TRIM24 (0.52) ALDH1A1KDM4ESMN1; SMN2CA12CA1
SCHEMBL13066508 0.71 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL1967 0.70 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDSMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 ALDH1A1 1488/4885KDM4E 3406/4885HPGD 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.